iRhythm Holdings (IRTC) Cash & Current Investments (2015 - 2026)
iRhythm Holdings (IRTC) reported Cash & Current Investments of $549.6 million for Q1 2026, up 5.58% year-over-year from $520.6 million in Q1 2025, and up 12.13% quarter-over-quarter from $490.2 million in Q4 2025.
iRhythm Holdings (IRTC) Cash & Current Investments (2015 - 2026) Analysis & Trends
iRhythm Holdings (IRTC) has 12 years of Cash & Current Investments data on file, last reported at $549.6 million in Q1 2026.
- Cash & Current Investments for Q1 2026 came in at $549.6 million, up 5.58% year-over-year; the trailing twelve-month figure through Mar 2026 was $549.6 million (up 5.58% YoY), and the FY2025 annual result was $490.2 million, down 8.47% from the prior year.
- Cash & Current Investments rose to $549.6 million in Q1 2026 per IRTC's latest filing, from $490.2 million in the prior quarter.
- Over five years, Cash & Current Investments peaked at $569.1 million in Q1 2024 and troughed at $133.8 million in Q4 2023.
- A 5-year average of $360.9 million and a median of $472.1 million in 2025 frame the typical range for Cash & Current Investments.
- The sharpest annual moves came in 2022 and 2024: Cash & Current Investments tumbled 38.71% in 2022, then soared 300.37% in 2024.
- A 5-year view of Cash & Current Investments shows it stood at $213.1 million in 2022, then plunged by 37.24% to $133.8 million in 2023, then soared by 300.37% to $535.6 million in 2024, then retreated by 8.47% to $490.2 million in 2025, then gained by 12.13% to $549.6 million in 2026.
- Business Quant data shows IRTC's Cash & Current Investments at $549.6 million in Q1 2026, $490.2 million in Q4 2025, and $472.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 7.30 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 8.38 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 3.67 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 3.12 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 1.12 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 2.29 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 439.60 Mn |
| 10 | iRhythm Holdings | 3.41 Bn | 2.86 Bn | 141.35 Mn | 549.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 549.62 Mn |
| Dec 31, 2025 | 490.17 Mn |
| Sep 30, 2025 | 472.07 Mn |
| Jun 30, 2025 | 545.54 Mn |
| Mar 31, 2025 | 520.59 Mn |
| Dec 31, 2024 | 535.55 Mn |
| Sep 30, 2024 | 522.03 Mn |
| Jun 30, 2024 | 561.46 Mn |
| Mar 31, 2024 | 569.09 Mn |
| Dec 31, 2023 | 133.76 Mn |
| Sep 30, 2023 | 158.47 Mn |
| Jun 30, 2023 | 164.74 Mn |
| Mar 31, 2023 | 176.34 Mn |
| Dec 31, 2022 | 213.14 Mn |
| Sep 30, 2022 | 157.03 Mn |
| Jun 30, 2022 | 156.71 Mn |
| Mar 31, 2022 | 208.78 Mn |
| Dec 31, 2021 | 239.13 Mn |
| Sep 30, 2021 | 221.80 Mn |
| Jun 30, 2021 | 255.66 Mn |